• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化由 spp. 引起的甲真菌病的治疗方法:载有两性霉素B的指甲油。 (注:原文中“spp.”表述不完整,可能影响对完整意思的理解)

Polishing the Therapy of Onychomycosis Induced by spp.: Amphotericin B-Loaded Nail Lacquer.

作者信息

Souza Aleph M S, Ribeiro Renato C A, Pinheiro Gleyse K L O, Pinheiro Francisco I, Oliveira Wógenes N, Souza Luanda B F C, Silva André L, Amaral-Machado Lucas, Alencar Éverton N, Chaves Guilherme M, Egito Eryvaldo S T

机构信息

Graduate Program in Pharmaceutical Sciences, Federal University of Rio Grande do Norte (UFRN), Natal 59012-570, Brazil.

Graduate Program in Health Sciences, Federal University of Rio Grande do Norte (UFRN), Natal 59012-570, Brazil.

出版信息

Pharmaceutics. 2021 May 24;13(6):784. doi: 10.3390/pharmaceutics13060784.

DOI:10.3390/pharmaceutics13060784
PMID:34073997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8225016/
Abstract

Onychomycosis induced by spp. has several limitations regarding its treatment. Nail lacquers display the potential to overcome these drawbacks by providing therapeutic compliance and increasing local drug bioavailability. Thus, this work aimed to produce a nail lacquer loaded with Amphotericin B (AmB) and evaluate its performance. The AmB-loaded nail lacquer was produced and preliminarily characterized. An AmB quantification method was developed. Stability, drug release, permeability and anti- activity assays were conducted. The analytical method validation met the acceptance criteria. The drug loading efficiency was 100% (0.02 mg/g of total product), whereas the AmB stability was limited to ≅7 days (≅90% remaining). The nail lacquer displayed a drying time of 187 s, non-volatile content of around 20%, water-resistance of approximately 2% of weight loss and satisfactory in vitro adhesion. Moreover, the in vitro antifungal activity against different spp. strains was confirmed. The AmB release and the ex vivo permeability studies revealed that AmB leaves the lacquer and permeates the nail matrix in 47.76 ± 0.07% over 24 h. In conclusion, AmB-loaded nail lacquer shows itself as a promising extemporaneous dosage form with remarkable anti- activity related to onychomycosis.

摘要

由 种引起的甲癣在治疗方面存在若干局限性。指甲油通过提供治疗依从性和提高局部药物生物利用度,显示出克服这些缺点的潜力。因此,本研究旨在制备一种载有两性霉素B(AmB)的指甲油并评估其性能。制备了载有AmB的指甲油并进行了初步表征。开发了一种AmB定量方法。进行了稳定性、药物释放、渗透性和抗活性测定。分析方法验证符合验收标准。载药效率为100%(每克总产品含0.02毫克),而AmB的稳定性限制在约7天(剩余约90%)。该指甲油的干燥时间为187秒,非挥发性含量约为20%,耐水性约为重量损失的2%,体外粘附性良好。此外,还证实了其对不同 种菌株的体外抗真菌活性。AmB释放和离体渗透性研究表明,在24小时内,AmB从指甲油中释放出来并渗透到指甲基质中的比例为47.76±0.07%。总之,载有AmB的指甲油显示出自身是一种有前途的临时剂型,对甲癣具有显著的抗活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/8225016/39316d953486/pharmaceutics-13-00784-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/8225016/a1f6fadedbc1/pharmaceutics-13-00784-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/8225016/93cec6b59c31/pharmaceutics-13-00784-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/8225016/2fbb7a81f786/pharmaceutics-13-00784-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/8225016/0c896d00b51d/pharmaceutics-13-00784-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/8225016/6fa3a7a010ec/pharmaceutics-13-00784-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/8225016/39316d953486/pharmaceutics-13-00784-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/8225016/a1f6fadedbc1/pharmaceutics-13-00784-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/8225016/93cec6b59c31/pharmaceutics-13-00784-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/8225016/2fbb7a81f786/pharmaceutics-13-00784-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/8225016/0c896d00b51d/pharmaceutics-13-00784-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/8225016/6fa3a7a010ec/pharmaceutics-13-00784-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/8225016/39316d953486/pharmaceutics-13-00784-g003.jpg

相似文献

1
Polishing the Therapy of Onychomycosis Induced by spp.: Amphotericin B-Loaded Nail Lacquer.优化由 spp. 引起的甲真菌病的治疗方法:载有两性霉素B的指甲油。 (注:原文中“spp.”表述不完整,可能影响对完整意思的理解)
Pharmaceutics. 2021 May 24;13(6):784. doi: 10.3390/pharmaceutics13060784.
2
Luliconazole Nail Lacquer for the Treatment of Onychomycosis: Formulation, Characterization and In Vitro and Ex Vivo Evaluation.卢立康唑搽剂治疗甲真菌病:制剂、表征及体外和体内评价。
AAPS PharmSciTech. 2022 Jun 24;23(6):175. doi: 10.1208/s12249-022-02324-7.
3
Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.水溶药物指甲漆:体外药物渗透及其相应的抗真菌活性。
Br J Dermatol. 2010 Feb 1;162(2):311-7. doi: 10.1111/j.1365-2133.2009.09504.x. Epub 2009 Nov 3.
4
Application of central composite design for the optimization of itraconazole loaded nail lacquer formulation.应用中心复合设计优化伊曲康唑载药指甲油配方。
3 Biotech. 2021 Jul;11(7):324. doi: 10.1007/s13205-021-02862-0. Epub 2021 Jun 11.
5
Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.基于环吡酮胺的优化 Eudragit RLPO 指甲油:作为渗透增强剂的内肽酶对经皮药物递送和抗甲真菌病的效率的影响。
AAPS PharmSciTech. 2018 Apr;19(3):1048-1060. doi: 10.1208/s12249-017-0917-8. Epub 2017 Nov 14.
6
Nail Lacquer Containing and Essential Oils and Biogenic Silver Nanoparticles for Onychomycosis: Development, Characterization, and Evaluation of Antifungal Efficacy.含精油和生物源银纳米颗粒的指甲油治疗甲真菌病:开发、表征及抗真菌疗效评估
Antibiotics (Basel). 2024 Sep 17;13(9):892. doi: 10.3390/antibiotics13090892.
7
Hydroxypropyl chitosan nail lacquer of ciclopirox-PLGA nanocapsules for augmented in vitro nail plate absorption and onychomycosis treatment.环吡酮胺-PLGA 纳米囊包载羟丙基壳聚糖甲涂剂增强体外甲板吸收及治疗甲真菌病。
Drug Deliv. 2022 Dec;29(1):3304-3316. doi: 10.1080/10717544.2022.2144543.
8
Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis.盐酸特比萘芬双层指甲油治疗甲真菌病。
J Pharm Sci. 2010 Oct;99(10):4267-76. doi: 10.1002/jps.22150.
9
Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.8%环吡酮甲涂剂局部溶液治疗趾甲甲真菌病
J Am Acad Dermatol. 2000 Oct;43(4 Suppl):S70-80. doi: 10.1067/mjd.2000.109071.
10
Ciclopirox nail lacquer: a brush with onychomycosis.环吡酮甲涂剂:与甲癣的一次“接触”
Cutis. 2001 Aug;68(2 Suppl):13-6.

引用本文的文献

1
Nail Polishes: A Review on Composition, Presence of Toxic Components, and Inadequate Labeling.指甲油:关于成分、有毒成分的存在以及标签不充分的综述。
Dermatol Res Pract. 2025 Mar 6;2025:6330337. doi: 10.1155/drp/6330337. eCollection 2025.
2
Contemporary Techniques and Potential Transungual Drug Delivery Nanosystems for The Treatment of Onychomycosis.当代技术与经皮给药纳米系统治疗甲真菌病的潜在研究进展。
AAPS PharmSciTech. 2023 Jul 8;24(6):150. doi: 10.1208/s12249-023-02603-x.
3
Novel and Investigational Treatments for Onychomycosis.

本文引用的文献

1
Unveiling the Amphotericin B Degradation Pathway and Its Kinetics in Lipid-Based Solutions.揭示两性霉素 B 在脂基溶液中的降解途径及其动力学。
J Pharm Sci. 2021 Mar;110(3):1248-1258. doi: 10.1016/j.xphs.2020.11.004. Epub 2020 Nov 9.
2
Onychomycosis in children - review on treatment and management strategies.儿童甲癣——治疗与管理策略综述
J Dermatolog Treat. 2022 May;33(3):1213-1224. doi: 10.1080/09546634.2020.1810607. Epub 2020 Aug 26.
3
Onychomycosis: a review.甲癣:综述
甲癣的新型和研究性治疗方法。
J Fungi (Basel). 2022 Oct 14;8(10):1079. doi: 10.3390/jof8101079.
4
Ciclopirox Hydroxypropyl Chitosan (CPX-HPCH) Nail Lacquer and Breathable Cosmetic Nail Polish: In Vitro Evaluation of Drug Transungual Permeation Following the Combined Application.环吡酮羟丙基壳聚糖(CPX-HPCH)指甲油和透气型美容指甲油:联合应用后药物经指甲渗透的体外评价
Life (Basel). 2022 May 27;12(6):801. doi: 10.3390/life12060801.
5
Printing Drugs onto Nails for Effective Treatment of Onychomycosis.将药物打印在指甲上以有效治疗灰指甲
Pharmaceutics. 2022 Feb 19;14(2):448. doi: 10.3390/pharmaceutics14020448.
6
In Silico Drug Screening Based Development of Novel Formulations for Onychomycosis Management.基于计算机药物筛选开发用于甲癣治疗的新型制剂
Gels. 2021 Nov 18;7(4):221. doi: 10.3390/gels7040221.
7
Constant Voltage Iontophoresis Technique to Deliver Terbinafine via Transungual Delivery System: Formulation Optimization Using Box-Behnken Design and In Vitro Evaluation.通过经甲递送系统递送特比萘芬的恒压离子电渗技术:使用Box-Behnken设计的制剂优化及体外评价
Pharmaceutics. 2021 Oct 15;13(10):1692. doi: 10.3390/pharmaceutics13101692.
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1972-1990. doi: 10.1111/jdv.16394. Epub 2020 Jun 5.
4
Diagnostic testing for onychomycosis: A retrospective study over 17 years.甲癣的诊断检测:一项为期17年的回顾性研究。
J Am Acad Dermatol. 2020 Jul;83(1):239-241. doi: 10.1016/j.jaad.2019.12.019. Epub 2019 Dec 14.
5
Recent Findings in Onychomycosis and Their Application for Appropriate Treatment.甲癣的最新研究发现及其在适当治疗中的应用
J Fungi (Basel). 2019 Feb 22;5(1):20. doi: 10.3390/jof5010020.
6
Onychomycosis: Clinical overview and diagnosis.甲真菌病:临床概述与诊断。
J Am Acad Dermatol. 2019 Apr;80(4):835-851. doi: 10.1016/j.jaad.2018.03.062. Epub 2018 Jun 28.
7
Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.基于环吡酮胺的优化 Eudragit RLPO 指甲油:作为渗透增强剂的内肽酶对经皮药物递送和抗甲真菌病的效率的影响。
AAPS PharmSciTech. 2018 Apr;19(3):1048-1060. doi: 10.1208/s12249-017-0917-8. Epub 2017 Nov 14.
8
Causative Agents of Onychomycosis: A 7-Year Study.甲癣的致病原:一项为期7年的研究。
J Clin Lab Anal. 2016 Nov;30(6):1013-1020. doi: 10.1002/jcla.21973. Epub 2016 Apr 13.
9
Epidemiology and fungal species distribution of superficial mycoses in Northeast Brazil.巴西东北部浅表真菌病的流行病学及真菌种类分布
J Mycol Med. 2017 Mar;27(1):57-64. doi: 10.1016/j.mycmed.2016.08.009. Epub 2016 Sep 20.
10
Development of ciclopirox nail lacquer with enhanced permeation and retention.开发具有增强渗透和滞留作用的环吡酮胺指甲油。
Arch Pharm Res. 2016 Jul;39(7):953-9. doi: 10.1007/s12272-016-0774-0. Epub 2016 Jun 15.